Final analysis of phase I results for BrevaRex presented to American Society of Hematology Dec. 7, 2000
Antigenics expands pancreatic cancer phase I/II trial following positive data with Oncophage vaccine Dec. 6, 2000
Potential cellular mechanism for adverse cardiac effects of Herceptin described at AHA sessions Nov. 16, 2000
RSS